An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
Clinical trial NCT03896295 · TERMINATED
Trial details
- NCT number
- NCT03896295
- Sponsor
- Momenta Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2020-12-09
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.